These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 2279532

  • 1. Effects of chronic administration of somatostatin analogue SMS 201-995 on the progression of chronic renal failure in subtotal nephrectomized rats.
    Uemasu J, Tokumoto A, Godai K, Kawasaki H, Hirayama C.
    Exp Clin Endocrinol; 1990 Sep; 96(1):97-104. PubMed ID: 2279532
    [Abstract] [Full Text] [Related]

  • 2. Reduced glomerular hypertrophy by somatostatin analog, SMS 201-995, in the subtotal nephrectomized rats fed high-protein meals.
    Uemasu J, Godai K, Tokumoto A, Kawasaki H.
    J Pharmacol Exp Ther; 1992 Feb; 260(2):505-8. PubMed ID: 1738100
    [Abstract] [Full Text] [Related]

  • 3. Effects of protease therapy in the remnant kidney model of progressive renal failure.
    Sebekova K, Paczek L, Dämmrich J, Ling H, Spustova V, Gaciong Z, Heidland A.
    Miner Electrolyte Metab; 1997 Feb; 23(3-6):291-5. PubMed ID: 9387136
    [Abstract] [Full Text] [Related]

  • 4. Effect of long-term administration of somatostatin analogue on renal enlargement in uninephrectomized-diabetic rats.
    Kim YS, Choi YJ, Jin DC, Chang YS, Yoon YS, Bang BK.
    J Korean Med Sci; 1993 Apr; 8(2):127-34. PubMed ID: 8397929
    [Abstract] [Full Text] [Related]

  • 5. Reductions in renal mass and the nephropathy induced by mercury.
    Zalups RK.
    Toxicol Appl Pharmacol; 1997 Apr; 143(2):366-79. PubMed ID: 9144453
    [Abstract] [Full Text] [Related]

  • 6. Comparative effects of captopril and enalapril on the progression of chronic renal disease in partially nephrectomized rats.
    Fettman MJ, Wilke WL, VanHouten DS, Hamar DW, Mikita DJ.
    Res Commun Chem Pathol Pharmacol; 1989 Aug; 65(2):131-46. PubMed ID: 2555851
    [Abstract] [Full Text] [Related]

  • 7. Effects of antihypertensive agents on blood pressure and the progress of renal failure in partially nephrectomized spontaneously hypertensive rats.
    Katsumata H, Suzuki H, Ohishi A, Nakamoto H, Saruta T, Sakaguchi H.
    Lab Invest; 1990 Apr; 62(4):474-80. PubMed ID: 2185377
    [Abstract] [Full Text] [Related]

  • 8. Effects of probucol in renal function and structure in rats with subtotal kidney ablation.
    Modi KS, Schreiner GF, Purkerson ML, Klahr S.
    J Lab Clin Med; 1992 Aug; 120(2):310-7. PubMed ID: 1500828
    [Abstract] [Full Text] [Related]

  • 9. [Molecular mechanisms of nephro-protective action of enalapril in experimental chronic renal failure].
    Ciechanowicz A.
    Ann Acad Med Stetin; 1999 Aug; Suppl 52():1-93. PubMed ID: 10589103
    [Abstract] [Full Text] [Related]

  • 10. Effect of propranolol on progression of chronic renal disease in partially nephrectomized rats.
    Radin MJ, Wilke WL, Fettman MJ.
    Res Commun Chem Pathol Pharmacol; 1987 Jul; 57(1):3-13. PubMed ID: 3671878
    [Abstract] [Full Text] [Related]

  • 11. Oral carbonaceous absorbent modifies renal function of renal ablation model without affecting plasma renin-angiotensin system or protein intake.
    Horike K, Usami T, Kamiya Y, Kamiya T, Yoshida A, Itoh S, Yamato H, Ise M, Kimura G.
    Clin Exp Nephrol; 2003 Jun; 7(2):120-4. PubMed ID: 14586730
    [Abstract] [Full Text] [Related]

  • 12. Renal protective effects of amlodipine on partially nephrectomized spontaneously hypertensive rats fed a high-salt diet.
    Kanno Y, Suzuki H, Okada H, Saruta T.
    J Cardiovasc Pharmacol; 1994 Mar; 23(3):480-4. PubMed ID: 7515994
    [Abstract] [Full Text] [Related]

  • 13. Combination of exercise and enalapril enhances renoprotective and peripheral effects in rats with renal ablation.
    Kanazawa M, Kawamura T, Li L, Sasaki Y, Matsumoto K, Kataoka H, Ito O, Minami N, Sato T, Ootaka T, Kohzuki M.
    Am J Hypertens; 2006 Jan; 19(1):80-6. PubMed ID: 16461196
    [Abstract] [Full Text] [Related]

  • 14. Carbonic adsorbent AST-120 retards progression of renal failure by additive effect with ACEI and protein restriction diet.
    Imai E, Takenaka M, Isaka Y, Moriyama T, Akagi Y, Kakuchi J, Fujii T, Ito T, Hori M, Horio M, Syoji T, Tsubakihara Y.
    Clin Exp Nephrol; 2003 Jun; 7(2):113-9. PubMed ID: 14586729
    [Abstract] [Full Text] [Related]

  • 15. Progressive losses of renal mass and the renal and hepatic disposition of administered inorganic mercury.
    Zalups RK.
    Toxicol Appl Pharmacol; 1995 Jan; 130(1):121-31. PubMed ID: 7839359
    [Abstract] [Full Text] [Related]

  • 16. The control of hypertension and its effect on renal function in rat remnant kidney.
    Eliahou HE, Cohen D, Herzog D, Shechter P, Serban I, Kapuler S, Schiby G, Gavendo S.
    Nephrol Dial Transplant; 1988 Jan; 3(1):38-44. PubMed ID: 3132638
    [Abstract] [Full Text] [Related]

  • 17. Kinin and angiotensin II receptor antagonists in rats with chronic renal failure: chronic effects on cardio- and renoprotection of angiotensin converting enzyme inhibitors.
    Kohzuki M, Kanazawa M, Liu PF, Kamimoto M, Yoshida K, Saito T, Yasujima M, Sato T, Abe K.
    J Hypertens; 1995 Dec; 13(12 Pt 2):1785-90. PubMed ID: 8903652
    [Abstract] [Full Text] [Related]

  • 18. Effect of clonidine on the progression of chronic renal disease in partially nephrectomized rats.
    Wilke WL, Fettman MJ, Tan AA.
    Res Commun Chem Pathol Pharmacol; 1987 Aug; 57(2):161-72. PubMed ID: 2821594
    [Abstract] [Full Text] [Related]

  • 19. Protective role of gamma-aminobutyric acid against chronic renal failure in rats.
    Sasaki S, Yokozawa T, Cho EJ, Oowada S, Kim M.
    J Pharm Pharmacol; 2006 Nov; 58(11):1515-25. PubMed ID: 17132215
    [Abstract] [Full Text] [Related]

  • 20. Effect of long-acting calcium entry blocker (anipamil) on blood pressure, renal function and survival of uremic rats.
    Jarusiripipat C, Chan L, Shapiro JI, Schrier RW.
    J Pharmacol Exp Ther; 1992 Jan; 260(1):243-7. PubMed ID: 1731040
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.